Press Release Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) 4 hours ago
Press Release Spero Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update on August 12, 2026 Aug 4
Press Release Spero Therapeutics Appoints Debra Jeske Zack, M.D., Ph.D., as Chief Medical Officer Jul 27